Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Healio15h
Increase in online searches for obesity drugs correlates with rise in prescriptions
The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...
Are weight-loss drugs like gym memberships? The answer is worth billions
An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
GMA18h
Josh Gad opens up for 1st time about taking weight loss drug: 'It is life-changing'
During his appearance on the " Armchair Expert " podcast on Monday, the "Frozen" actor opened up about taking weight loss ...
How to Save on Weight Loss Drugs: Navigating Insurance and Discounts
Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.
With Inflation, Slowdown, Trade Wars Risks, Why Are Investors Returning to Europe?
Euro US Dollar, Compagnie Financiere Richemont SA, Burberry Group PLC, ASML Holding NV. Read Jakub Rochlitz's latest article on Investing.com ...
Josh Gad reveals he had to stop taking weight-loss drug due to side effects: ‘Really bummed out’
Josh Gad has opened up for the first time about using GLP-1 medication for weight loss and his seesaw experience with the ...
BioPharma Dive15h
FDA clears use of Ozempic to protect kidney health
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
Becker's Hospital Review11h
GLP-1 drug approvals: A breakdown
Discover the FDA-approved indications for GLP-1 receptors, including diabetes, weight loss, and cardiovascular disease. Learn brand-name and generic options.